References

Question 1, 4, 12:

Crocetti L, Della Pina C, Cioni D, Lencioni R. Peri-intra- procedural imaging: US, CT, and MRI. Abdom Imaging 2011;36(6):648–660.

Question 2-3, 5, 7, 15:

Bajpai, S., Kambadakone, A., Guimaraes, A. R., Arellano, R. S., Gervais, D. A., & Sahani, D. (2015). Image-guided treatment in the hepatobiliary system: Role of imaging in treatment planning and posttreatment evaluation. Radiographics, 35(5), 1393–1418.

Question 6:

Bester L, Meteling B, Boshell D, Chua TC, Morris DL. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature. J Med Imaging Radiat Oncol 2014;58(3):341–352

Question 8:

Arellano RS, Garcia RG, Gervais DA, Mueller PR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol 2009;193(6):1686–1690.

Question 9:

Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23–30

Question 10:

Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 2010;254(1):154–162.

Question 11:

Brennan IM, Ahmed M. Imaging features following trans- arterial chemoembolization and radiofrequency ablation of hepatocellular carcinoma. Semin Ultrasound CT MR 2013;34(4):336–351.

Question 13:

Agrawal MD, Pinho DF, Kulkarni NM, Hahn PF, Guimaraes AR, Sahani DV. Oncologic applications of dual-energy CT in the abdomen. RadioGraphics 2014;34(3):589–612

Question 14:

Chandarana H, Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol 2010;76(3):348–358.